TABLE 3.
LAE | SAE | |||
---|---|---|---|---|
Regression Coefficient (95% CI) | P | Regression Coefficient (95% CI) | P | |
Model 1 (Framingham score) | ||||
HIV infected (vs. non infected) | −2.36 (−4.56 to −0.17) | 0.04 | −1.31 (−2.52 to −0.09) | 0.04 |
Model 2 (smoking, IDU, hepatitis C, and HDLc) | ||||
HIV infected (vs. non infected) | −2.67 (−4.97 to −0.38) | 0.02 | −1.13 (−2.35 to −0.09) | 0.07 |
Model 3 (fully adjusted) | ||||
HIV infected (vs. non infected) | −2.91 (−5.29 to −0.53) | 0.02 | −1.34 (−2.50 to −0.17) | 0.03 |
Regression coefficients represent the adjusted differences in LAE or SAE in HIV-infected participants vs. controls. Model 1 considers Framingham 10-year CVD risk score as a covariate; model 2 considers smoking status, history of IDU, hepatitis C infection, and HDLc level; and model 3 considers age, sex, race/ethnicity, smoking status, history of IDU, hepatitis C infection, HDLc, and non-HDLc levels.
CI, confidence interval.